Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target

Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target

Prostate cancer (PCa) is the second most common cancer among men worldwide. The main screening tool remains the prostate-specific antigen (PSA), which shows significant limitations, including poor sensitivity/specificity. Therefore, establishing accurate non-invasive diagnostic biomarkers remains an...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonio J. Montero-Hidalgo, Enrique Gómez-Gómez, Manuel Galán-Cañete, Francisco Porcel-Pastrana, Jesús M. Pérez-Gómez, María Ortega-Bellido, Julia Carrasco-Valiente, Laura Chamorro-Castillo, Juan P. Campos-Hernández, Oriol A. Rangel-Zuñiga, Teresa González-Serrano, Rafael Sánchez-Sánchez, André Sarmento-Cabral, Manuel D. Gahete, Juan M. Jiménez-Vacas, Raúl M. Luque
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Molecular Therapy: Oncology
Subjects:
MT: Novel therapeutic targets and biomarker development Special Issue
SRRM1
SNRNP200
SRSF3
prostate cancer
biomarker
Online Access:http://www.sciencedirect.com/science/article/pii/S2950329924001528
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2950329924001528

Similar Items